Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section
Photo of Gregory S. Calip

Gregory S. Calip

Assistant Professor, Pharmacy Systems, Outcomes and Policy

Center Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research

Contact Information

833 South Wood Street (871)
Room 287C, College of Pharmacy
Chicago, IL 60612

Phone: (312) 355-5318

Fax: (312) 996-2954

Education

  • Postdoctoral Fellowship, Cancer Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, 2014
  • PhD, Epidemiology, University of Washington, Seattle, WA, 2014
  • MPH, Biostatistics & Epidemiology, New York University, New York, NY, 2010
  • PharmD, Pharmacy, University of Illinois at Chicago, Chicago, IL, 2008

Research Interests

Dr. Gregory Calip is an Assistant Professor in the Department of Pharmacy Systems, Outcomes and Policy, Center for Pharmacoepidemiology and Pharmacoeconomic Research at the University of Illinois at Chicago (UIC). He is an alumnus of the UIC College of Pharmacy where he completed his PharmD before pursuing his MPH in Biostatistics at New York University and PhD in Epidemiology at the University of Washington. He completed additional training in cancer epidemiology and prevention as postdoctoral fellow at the Fred Hutchinson Cancer Research Center in Seattle, where he remains an affiliate investigator. Dr. Calip’s primary research interests are related to comorbidity and treatment-related sequelae among cancer survivors. Dr. Calip is recipient of the Hans W. Vahlteich Research Scholar Award and has received grants from the National Institutes of Health, National Heart, Lung and Blood Institute and National Center for Advancing Translational Sciences to support his research on cancer treatment-related cardiotoxicity.

Teaching Interests

Epidemiologic Methods, Clinical Epidemiology

Intellectual Contributions

Journal Article

  • Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT. "Risk of Amputations Associated with SGLT2 Inhibitors Compared to DPP-4 Inhibitors: A Propensity-Matched Cohort Study.". Diabetes, obesity & metabolism. 2018;. doi:10.1111/dom.13459.
  • Zhou J, Han J, Nutescu EA, Gordeuk VR, Saraf SL, Calip GS. "Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study.". British journal of haematology. 2018;. doi:10.1111/bjh.15396.
  • Xing S, Kim S, Schumock GT, Touchette D, Calip GS, Leow AD, Lee TA. "Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.". The primary care companion for CNS disorders. 2018;20(3). doi:10.4088/PCC.17m02220.
  • Xing S, Calip GS, Leow AD, Kim S, Schumock GT, Touchette D, Lee TA. "The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.". Journal of diabetes and its complications. 2018;32(5):492-500. doi:10.1016/j.jdiacomp.2017.12.008.
  • Sweiss KI, Oh A, Calip GS, Rondelli D, Patel P. "Similar survival but increased toxicity with a sequential versus concurrent FluBu4 regimen.". Bone marrow transplantation. 2018;. doi:10.1038/s41409-018-0195-4.
  • Calip GS, Patel PR, Adimadhyam S, Xing S, Wu Z, Sweiss KI, Schumock GT, Lee TA, Chiu BC. "Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions.". International journal of cancer. 2018;. doi:10.1002/ijc.31407.
  • Lee WJ, Lee TA, Calip GS, Suda K, Briars LA, Schumock GT. "Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.". Inflammatory bowel diseases. 2018;24(4):883-891. doi:10.1093/ibd/izx080.
  • Zueger PM, Holmes HM, Calip GS, Qato D, Pickard AS, Lee TA. "Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice.". Journal of the American Geriatrics Society. 2018;. doi:10.1111/jgs.15328.
  • Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. "Predicting Acute Exacerbations in Chronic Obstructive Pulmonary Disease.". Journal of managed care & specialty pharmacy. 2018;24(3):265-279. doi:10.18553/jmcp.2018.24.3.265.
  • Lee WJ, Lee TA, Suda K, Calip GS, Briars LA, Schumock GT. "Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis.". Rheumatology (Oxford, England). 2018;57(2):273-282. doi:10.1093/rheumatology/kex049.
  • Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. "Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β2-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid.". The Annals of pharmacotherapy. 2017;51(11):945-953. doi:10.1177/1060028017719716.
  • Calip GS, Adimadhyam S, Xing S, Rincon JC, Lee WJ, Anguiano RH. "Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions.". Seminars in arthritis and rheumatism. 2017;47(2):157-164. doi:10.1016/j.semarthrit.2017.03.010.
  • Abhyankar N, Hoskins KF, Abern MR, Calip GS. "Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.". BMC cancer. 2017;17(1):659. doi:10.1186/s12885-017-3640-7.
  • Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS. "Characterization of opioid use in sickle cell disease.". Pharmacoepidemiology and drug safety. 2017;. doi:10.1002/pds.4291.
  • Han J, Zhou J, Kondragunta V, Zhang X, Molokie RE, Gowhari M, Hassan J, Jain S, Calip GS, Gordeuk VR, Saraf SL. "Erythropoiesis-stimulating agents in sickle cell anaemia.". British journal of haematology. 2017;. doi:10.1111/bjh.14846.
  • Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Rupérez M, Macete E, Menéndez C, Nakanabo-Diallo S, Kazienga A, Valéa I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d'Alessandro U, Nosten F, Ter Kuile F, Stergachis A. "First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies.". PLoS medicine. 2017;14(5):e1002290. doi:10.1371/journal.pmed.1002290.
  • Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY. "Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer.". Journal of oncology practice. 2017;13(5):e451-e462. doi:10.1200/JOP.2016.018317.
  • Wirtz HS, Calip GS, Buist DSM , Gralow JR, Barlow WE, Gray S, Boudreau DM. "Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.". American journal of epidemiology. 2017;185(8):661-672. doi:10.1093/aje/kww242.
  • Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. "Comparative Effectiveness of Long-Acting Beta2 -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.". Pharmacotherapy. 2017;37(4):447-455. doi:10.1002/phar.1913.
  • Calip GS, Elmore JG, Boudreau DM. "Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.". Breast cancer research and treatment. 2017;161(1):161-172. doi:10.1007/s10549-016-4043-1.
  • Lee WJ, Briars LA, Lee TA, Calip GS, Suda KJ, Suda GT. "Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.". Pharmacotherapy. 2016;36(12):1201-1209. doi:10.1002/phar.1856.
  • Lee WJ, Briars LA, Lee TA, Calip GS, Suda KJ, Schumock GT. "Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.". Inflammatory bowel diseases. 2016;22(10):2410-7. doi:10.1097/MIB.0000000000000880.
  • Malmgren JA, Calip GS, Pyott SM, Atwood MK, Kaplan HG. "Therapy-related myelodysplastic syndrome following primary breast cancer.". Leukemia research. 2016;47:178-184. doi:10.1016/j.leukres.2016.06.005.
  • Calip GS, Yu O, Elmore JG, Boudreau DM. "Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.". Cancer causes & control : CCC. 2016;27(5):709-20. doi:10.1007/s10552-016-0744-3.
  • Dellicour S, Aol G, Ouma P, Yan N, Bigogo G, Hamel MJ, Burton DC, Oneko M, Breiman RF, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Calip G, Stergachis A, Laserson KF, Ter Kuile FO, Desai M. "Weekly miscarriage rates in a community-based prospective cohort study in rural western Kenya.". BMJ open. 2016;6(4):e011088. doi:10.1136/bmjopen-2016-011088.
  • Solanki PA, Ko NY, Qato DM, Calip GS. "Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991-2011.". SpringerPlus. 2016;5:82. doi:10.1186/s40064-016-1726-3.
  • Tinto H, Sevene E, Dellicour S, Calip GS, d'Alessandro U, Macete E, Nakanabo-Diallo S, Kazienga A, Valea I, Sorgho H, Valá A, Augusto O, Ruperez M, Menendez C, Ouma P, Desai M, Ter Kuile F, Stergachis A. "Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.". Reproductive health. 2015;12(1):112. doi:10.1186/s12978-015-0101-0.
  • Dellicour S, Desai M, Aol G, Oneko M, Ouma P, Bigogo G, Burton DC, Breiman RF, Hamel MJ, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Pandit J, Laserson KF, Calip G, Stergachis A, ter Kuile FO. "Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya.". Malaria journal. 2015;14(1):461. doi:10.1186/s12936-015-0950-6.
  • Calip GS, Malmgren JA, Lee WJ, Schwartz SM, Kaplan HG. "Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.". Breast cancer research and treatment. 2015;154(1):133-43. doi:10.1007/s10549-015-3590-1.
  • Calip GS, Yu O, Hoskins KF, Boudreau DM. "Associations between diabetes medication use and risk of second breast cancer events and mortality.". Cancer causes & control : CCC. 2015;26(8):1065-77. doi:10.1007/s10552-015-0599-z.
  • Kaplan HG, Malmgren JA, Atwood MK, Calip GS. "Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007.". Cancer. 2015;121(15):2553-61. doi:10.1002/cncr.29371.
  • Calip GS, Law EH, Ko NY. "Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.". Breast cancer research and treatment. 2015;151(3):687-96. doi:10.1007/s10549-015-3439-7.
  • Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM. "Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.". Pharmacoepidemiology and drug safety. 2015;24(1):75-85. doi:10.1002/pds.3660.
  • Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM. "Metabolic syndrome and outcomes following early-stage breast cancer.". Breast cancer research and treatment. 2014;148(2):363-77. doi:10.1007/s10549-014-3157-6.
  • Kaplan HG, Malmgren JA, Li CI, Calip GS. "Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.". Breast cancer research and treatment. 2013;142(3):629-36. doi:10.1007/s10549-013-2773-x.
  • Monahan LJ, Calip GS, Novo PM, Sherstinsky M, Casiano M, Mota E, Dourado I. "Impact of the Family Health Program on gastroenteritis in children in Bahia, Northeast Brazil: an analysis of primary care-sensitive conditions.". Journal of epidemiology and global health. 2013;3(3):175-85. doi:10.1016/j.jegh.2013.03.002.
  • Calip GS, Boudreau DM, Loggers ET. "Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment.". Breast cancer research and treatment. 2013;138(1):225-33. doi:10.1007/s10549-013-2424-2.
  • Calip GS, McDougall JA, Wheldon MC, Li CI, De Roos AJ. "Evaluation of seasonality in the diagnosis of acute myeloid leukaemia among adults in the United States, 1992-2008.". British journal of haematology. 2013;160(3):343-50. doi:10.1111/bjh.12137.
  • Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons JK, Thompson IM, Kristal AR. "Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.". American journal of epidemiology. 2012;176(2):156-63. doi:10.1093/aje/kwr524.
  • Shelley D, Anno J, Tseng TY, Calip G, Wedeles J, Lloyd M, Wolff MS. "Implementing tobacco use treatment guidelines in public health dental clinics in New York City.". Journal of dental education. 2011;75(4):527-33.

Conference Proceeding

  • Chiu BC, Chen J, Yen Y, Calip GS, Chien C, Ahsan H, Shih YT, Cheng K ed. "Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study" . Blood. December-3-2015.
  • Calip GS, Lee WJ, Lee TA, Schumock GT, Chiu BC ed. "Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors" . Blood. December-3-2015.
  • Calip GS, Lee WJ, Lee TA, Schumock GT, Chiu BC ed. "Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma" . Blood. December-3-2015.
Top